4//SEC Filing
Rolfe Lindsey 4
Accession 0001213900-25-050123
CIK 0001870404other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:06 PM ET
Size
13.3 KB
Accession
0001213900-25-050123
Insider Transaction Report
Form 4
Rolfe Lindsey
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-30+9,326→ 9,326 totalExercise: $0.45Exp: 2035-05-29→ Common Stock (9,326 underlying)
Footnotes (1)
- [F1]Represents the 1/3 time-based portion of an award of options to purchase 27,979 shares, vesting in equal monthly installments on the 4th of each month from July 4, 2025 through March 4, 2026, with the remaining portion subject to performance conditions.
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001650504
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:06 PM ET
- Size
- 13.3 KB